# Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-or-cyclophosphamide-in-the-treatment-of-membranous-nephropathy-the-ri/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Francesco Scolari,Elisa Delbarba,Domenico Santoro,Loreto Gesualdo,Antonello Pani,Nadia Dallera,Laila‐Yasmin Mani,Marisa Santostefano,Sandro Feriozzi,Marco Quaglia,Giuliano Boscutti,Angelo Ferrantelli,Carmelita Marcantoni,Patrizia Passerini,Riccardo Magistroni,Federico Alberici,Gian Marco Ghiggeri,Claudio Ponticelli,Pietro Ravani,for the RI-CYCLO Investigators |
| Citations | 246 |
| DOI | 10.1681/asn.2020071091 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://boris.unibe.ch/153035/ |
| OpenAlex ID | https://openalex.org/W3133606094 |
| PMID | 33649098 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Domenico Santoro](https://scholariq.org/researchers/domenico-santoro/)
- [Riccardo Magistroni](https://scholariq.org/researchers/riccardo-magistroni/)
- [Loreto Gesualdo](https://scholariq.org/researchers/loreto-gesualdo/)

## Paper journal

- [Journal of the American Society of Nephrology](https://scholariq.org/journals/journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chemotherapy-induced organ toxicity mitigation](https://scholariq.org/topics/chemotherapy-induced-organ-toxicity-mitigation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.